Abstract:Background The mechanisms responsible for menstrual pain are poorly understood. However, dynamic noninvasive pelvic imaging of menstrual pain sufferers could aid in identifying therapeutic targets and in testing novel treatments. Objective To study the mechanisms responsible for menstrual pain, we analyzed ultrasonographic and complementary functional Magnetic Resonance Imaging (fMRI) parameters in dysmenorrhea sufferers and pain-free controls under multiple conditions. Study Design We performed fMRI on participants with and without dysmenorrhea during menses and non-menses. To clarify whether regional changes in oxygen availability and perfusion occur, fMRI R2* measurements were made of the endometrium and myometrium. R2* measurements are calculated nuclear magnetic resonance relaxation rates sensitive to the paramagnetic properties of oxygenated and deoxygenated hemoglobin. We also compared parameters before and after an analgesic dose of naproxen sodium. In addition, we performed similar measurements with Doppler ultrasonography to identify whether changes in uterine arterial velocity occurred during menstrual cramping in real time. Mixed model statistics were performed to account for within-subject effects across conditions. Corrections for multiple comparisons were made with a false discovery rate adjustment. Results During menstruation, a notable increase in R2* values, indicative of tissue ischemia, was observed in both the myometrium (beta ± standard error of the mean: 15.74 ± 2.29 s -1 , p = 0.001, q = 0.002) and the endometrium (26.37 ± 9.33 s -1 , p = 0.005, q = 0.008) among participants experiencing dysmenorrhea. A similar increase was noted in the myometrium (28.89 ± 2.85 s -1 , p = 0.001, q = 0.002) and endometrium (75.50 ± 2.57 s -1 , p = 0.001, q = 0.003) among pain-free controls. Post-hoc analyses revealed that R2* values during menstruation were significantly higher than those in participants with dysmenorrhea (Myometrium: p = 0.008, Endometrium: p = 0.043). Whereas naproxen sodium increased endometrial R2* in participants with dysmenorrhea (48.29 ± 15.78 s -1 , p = 0.005, q = 0.008), it decreased myometrial R2*in pain-free controls. Doppler findings were consistent with fMRI (-8.62 ± 3.25 s -1 , p = 0.008, q = 0.011). The pulsatility index (-0.42 ± 0.14, p = 0.004, q = 0.004) and resistance index (-0.042 ± 0.012, p = 0.001, q = 0.001) decreased during menses compared with non-menses, and effects were significantly reversed by naproxen sodium. Naproxen sodium had the opposite effect in pain-free controls. There were no significant real-time changes in the pulsatility index, resistance index, peak systolic velocity, or minimum diastolic velocity during episodes of symptomatic menstrual cramping. Conclusions fMRI and Doppler metrics suggest participants with dysmenorrhea have better perfusion and oxygen availability than pain-free controls. Naproxen sodium's therapeutic mechanism is associated with relative reductions in uterine perfusion and oxygen availability. An opposite pharmacological effect was observed in pain-free controls. During menstrual cramping, there is insufficient evidence of episodic impaired uterine perfusion. Thus, prostaglandins may have protective vasoconstrictive effects in pain-free controls and opposite effects among participants with dysmenorrhea.

Pulsed Red Photobiomodulation Boosts the Inhibition of Oxytocin‐Induced Primary Dysmenorrhea in Mice by Suppressing Oxidative Stress and Inflammation

Effect of photobiomodulation on alleviating primary dysmenorrhea caused by PGF2α

Bypassing the Heat Risk and Efficacy Limitations of Pulsed 630 nm LED Photobiomodulation Therapy for Anti-Primary Dysmenorrhea: A Prospective Randomized Cross-Over Trial

Pulsed Radiofrequency to the Dorsal Root Ganglion or the Sciatic Nerve Reduces Neuropathic Pain Behavior, Decreases Peripheral Pro-Inflammatory Cytokines and Spinal Β-Catenin in Chronic Constriction Injury Rats

NLRP3 inflammasome inhibitor MCC950 attenuates primary dysmenorrhea in mice via the NF-κB/COX-2/PG pathway

Peony Pollen Protects against Primary Dysmenorrhea in Mice by Inhibiting Inflammatory Response and Regulating the COX2/PGE2 Pathway

Photobiomodulation therapy reduces acute pain and inflammation in mice

Paeonol alleviates primary dysmenorrhea in mice via activating CB2R in the uterus

Effects of 940 Nm Low-Level Laser Therapy for the Treatment of Primary Dysmenorrhea: a Double-Blind, Randomized, Placebo-Controlled Trial

Photobiomodulation ameliorates ovarian aging by alleviating oxidative stress and inflammation damage and improving mitochondrial function

Effects of preventative moxibustion at Shenque (CV8) and Guanyuan (CV4) on BDNF-TrkB pathway in the spinal dorsal horn and hypothalamus in rats with dysmenorrhea

[Therapeutic effect of Leonuri Herba aqueous decoction on primary dysmenorrhea in rats and its metabolomic analysis]

Pulsed Electromagnetic Field Attenuates Osteoarthritis Progression in a Murine Destabilization-Induced Model through Inhibition of TNF-α and IL-6 Signaling

The Inhibitory Effect of Extra Virgin Olive Oil and Its Active Compound Oleocanthal on Prostaglandin-Induced Uterine Hypercontraction and Pain-Ex Vivo and In Vivo Study

Photobiomodulation reduces neuropathic pain after spinal cord injury by downregulating CXCL10 expression

The Therapeutic Effect of Ge-Gen Decoction on a Rat Model of Primary Dysmenorrhea: Label-Free Quantitative Proteomics and Bioinformatic Analyses

Ultrasound and MRI-based investigation of the role of perfusion and oxygen availability in menstrual pain

Photobiomodulation Therapy at 632 Nm Wavelength Ameliorates Intrauterine Adhesion Via Activation of Camp/pka/creb Pathway

Instant analgesic effect of radial extracorporeal shock wave therapy on primary dysmenorrhoea according to functional magnetic resonance imaging: study protocol for a randomised placebo-controlled trial

Combined Photobiomodulation and Static Magnetic Fields to Reduce Side Effects from Laser and Radiofrequency Treatments for Dermatological Conditions

Mechanism of Penehyclidine Hydrochloride on a Dysmenorrhea Rat Model